Cooper Companies (NASDAQ:COO) Shares Gap Up on Better-Than-Expected Earnings

The Cooper Companies, Inc. (NASDAQ:COO) gapped up prior to trading on Friday after the company announced better than expected quarterly earnings. The stock had previously closed at $62.02, but opened at $65.24. Cooper Companies shares last traded at $66.1170, with a volume of 1,427,147 shares trading hands.

The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the previous year, the firm posted $0.96 earnings per share. Cooper Companies’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Robert W. Baird lowered their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday. Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday. Barclays raised their target price on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Citigroup restated a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. Finally, The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $83.86.

Institutional Trading of Cooper Companies

Institutional investors have recently modified their holdings of the company. Root Financial Partners LLC raised its position in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares in the last quarter. SJS Investment Consulting Inc. boosted its position in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares in the last quarter. Bell Investment Advisors Inc boosted its position in shares of Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Cooper Companies in the 2nd quarter worth approximately $36,000. Finally, True Wealth Design LLC grew its stake in shares of Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The business’s fifty day moving average is $65.17 and its 200 day moving average is $74.57. The firm has a market capitalization of $12.96 billion, a P/E ratio of 32.86, a P/E/G ratio of 1.56 and a beta of 0.87.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.